Galectin-9, Human Recombinant | 7365

Galectin-9 (Gal-9) is a member of animal lectins that have an affinity to beta-galactosides and Forssman pentasaccharide. It is strongly overexpressed in Hodgkin's disease tissue and it might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its consistently associated immunodeficiency. Recombinant Galectin-9 protein was expressed in E.coli and purified by using conventional chromatography techniques.

7365 | Galectin-9 human recombinant DataSheet

Biomolecule/Target: Galectin-9

Synonyms: LGALS9, Gal-9, Tumor antigen HOM-HD-21, Ecalectin, Galectin 9, Galectin-9

Alternates names: LGALS9, Gal-9, Tumor antigen HOM-HD-21, Ecalectin, Galectin 9, Galectin-9

Taglines: A protein strongly overexpressed in Hodgkin's disease tissue.

NCBI Gene ID #: 2254

NCBI Gene Symbol: FGF9

Gene Source: Human

Accession #: P54130

Recombinant: Yes

Source: E. coli

Purity by SDS-PAGEs: 98%

Assay: SDS-PAGE

Purity: N/A

Assay #2: N/A

Endotoxin Level: N/A

Activity (Specifications/test method): N/A

Biological activity: The ED50 for this effect is equal to or less than 2.5 µg/ml. Measured by its ability to agglutinate human red blood cells.

Results: N/A

Binding Capacity: N/A

Unit Definition: N/A

Molecular Weight: 18.5 kDa (168 aa, 1-148 aa + His Tag).

Concentration: 0.5 mg/ml

Appearance: Liquid

Physical form description: 0.5 mg/ml in 20 mM Tris-HCl buffer (pH 8.0) containing 1 mM NaCl and 20% glycerol.

Reconstitution Instructions: N/A

Amino acid sequence: MGSSHHHHHH SSGLVPRGSH MAFSGSQAPY LSPAVPFSGT IQGGLQDGLQ ITVNGTVLSS SGTRFAVNFQ TGFSGNDIAF HFNPRFEDGG YVVCNTRQNG SWGPEERKTH MPFQKGMPFD LCFLVQSSDF KVMVNGILFV QYFHRVPFHR VDTISVNGSV QLSYISFQ